Immunic, Inc.
General ticker "IMUX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $104.3M (TTM average)
Immunic, Inc. does not follow the US Stock Market performance with the rate: -15.4%.
Estimated limits based on current volatility of 3.4%: low 0.64$, high 0.68$
Factors to consider:
- Total employees count: 77 (+16.7%) as of 2023
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Insufficient funding, Geopolitical risks, Limited operating history, Market competition, Regulatory and compliance
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.69$, 2.11$]
- 2025-12-31 to 2026-12-31 estimated range: [0.44$, 1.42$]
Financial Metrics affecting the IMUX estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -81.89 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of -0.26 > -0.66
- Positive: 41.86 < Shareholder equity ratio, % of 45.09 <= 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term IMUX quotes
Long-term IMUX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $119.49MM | $99.22MM | $98.05MM |
| Operating Income | $-119.49MM | $-99.22MM | $-98.05MM |
| Non-Operating Income | $-0.92MM | $5.61MM | $-2.46MM |
| R&D Expense | $71.25MM | $83.22MM | $80.05MM |
| Income(Loss) | $-120.41MM | $-93.61MM | $-100.51MM |
| Profit(Loss)* | $-120.41MM | $-93.61MM | $-100.51MM |
| Stockholders Equity | $113.68MM | $28.93MM | $18.43MM |
| Inventory | $5.61MM | $0.00MM | $0.00MM |
| Assets | $127.75MM | $54.30MM | $40.87MM |
| Operating Cash Flow | $-65.14MM | $-70.83MM | $-84.77MM |
| Capital expenditure | $0.11MM | $0.33MM | $0.26MM |
| Investing Cash Flow | $-9.74MM | $9.46MM | $-0.26MM |
| Financing Cash Flow | $95.76MM | $1.03MM | $74.54MM |
| Earnings Per Share** | $-3.78 | $-2.11 | $-1.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.